The Invisible Divide in Diabetes Care: Why Type 2 Patients Are Still Paying to Bleed

The future standard should be simple: If a patient requires intensive insulin management, that patient deserves access to modern glucose monitoring technology, regardless of whether the diagnosis says Type 1 or Type 2.
That is not radical. That is modern medicine catching up with reality. “Update: After consistently following my treatment plan and multiple discussions with my endocrinologist, I have been approved for a continuous glucose sensor as a person with type 2 diabetes. This remains an exception rather than standard practice.”

Ozempic, Side Effects, and the Cost of Medical Hype

This article tells the story of my experience with Ozempic and how my body reacted very badly to it. I explain that the side effects were not mild, but severe enough to stop the medication on my own. The text warns that Ozempic is often promoted as safe and easy, while serious problems are downplayed. The message is simple: medicines do not affect everyone the same way, and people should be fully informed and allowed to listen to their own bodies.